Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

More research is needed to understand and manage rheumatoid arthritis better.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Immune cells affect hair growth and could lead to new hair loss treatments.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.